News
Verzenio remains the only drug in the CDK4/6 class to be approved for adjuvant use in early breast cancer, which has helped it to buoyant sales growth, up 84% to nearly $2.5 billion last year.
From Lisa Rinna and Madonna's unclad mirror selfies to Naomi Campbell's magazine shoot, check out these 50-plus celebrities who've been photographed in the nude.
Get ESTX 50 PR INDEX (.STOXX50E) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ...
Updated July 4, 2025, 12:08 a.m. ET Early Prime Day Sale: Up to 50% Off Toys Get ready for the Early Prime Day Sale at Amazon, where you can save up to 50% on a wide selection of toys!
Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reported at the ...
CX-50: The CX-50 lineup starts at $28,025 in America, including destination. The 2.5 S trim includes niceties such as AWD, LED headlights, 17-inch alloys, and the 8.8-inch infotainment with ...
Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...
See the latest Eli Lilly and Co stock price (LLY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
Proton therapy is a type of external beam radiation therapy that delivers high dose radiation directly to cancer cells. Learn about its benefits and uses for breast cancer treatment.
you are here: Moneycontrol / Mutual Funds / Index Funds/ETFs / Tata Mutual Fund / Tata Nifty Midcap 150 Momentum 50 Index Fund - Direct Plan (G) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results